Sequential treatment for myopia control with orthokeratology and 0.01% atropine
Treatments studied
Part of Eyes & vision clinical trials.
This trial studies a two-step treatment for nearsightedness (myopia) in children. It first uses special contact lenses worn overnight (orthokeratology) followed by low-dose atropine eye drops to slow down worsening of nearsightedness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 8 and 15 years old.
- Your nearsightedness is between -0.50 and -6.00 diopters, with no more than -1.50 diopters of astigmatism in either eye.
- The difference in vision between your eyes is less than 1.50 diopters.
- Your best corrected vision is 20/25 or better (with glasses or contacts) in both eyes.
- You have normal eye pressure (below 21 mmHg) in both eyes.
- You have normal binocular (two-eye) vision and depth perception.
- You and your parent/guardian understand and agree to be randomly assigned to a treatment group.
- You have not used any myopia control treatments (like atropine, special glasses, or contact lenses) recently without a washout period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special contact lens combined with atropine eye drops to see if they work better together to slow down worsening nearsightedness (myopia) in children. It might be a good option if your child's eyes are getting more nearsighted and they haven't tried other treatments yet.
This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.